FDA Inspection 1207460 — Effingham Equity

Effingham Equity — FEI 1480885

The FDA completed an inspection of Effingham Equity on June 6, 2023 in Effingham, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 6, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Effingham, IL (United States)

Citations

IDCFRDescription
181121 CFR 225.58(b)(1)Three assays per year
2130121 CFR 507.34(a)(1)Preventive Controls